Radiation myelitis after pembrolizumab administration, with favorable clinical evolution and safe rechallenge: a case report and review of the literature

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 5 X users

Readers on

mendeley: 55 Mendeley

Summary X

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 39,174 followers.

#JITC Case Report: Radiation myelitis after pembrolizumab administration, with favorable clinical evolution and safe rechallenge: a case report and review of the literature https://t.co/YgVQmVnzOa https://t.co/pUDJ466Y3P

18 Dec 2019

Reply Repost Favourite

RT @gulleyj1: When is it safe to rechallenge with ICI after irAE? https://t.co/0oo5hC00uv

12 Dec 2019

Reply Repost Favourite

RT @gulleyj1: When is it safe to rechallenge with ICI after irAE? https://t.co/0oo5hC00uv

12 Dec 2019

Reply Repost Favourite

RT @gulleyj1: When is it safe to rechallenge with ICI after irAE? https://t.co/0oo5hC00uv

12 Dec 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.